Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Pilot Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis

NCT02978339 is registered in ClinicalTrials.gov with John E. Eaton as lead sponsor.

NCT NCT02978339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02978339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Pilot Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis
Lead sponsor
John E. Eaton
Phase
Phase 1/2
Overall status
Completed
Start date
June 9, 2017
Completion date
January 8, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary sclerosing cholangitis